Northern Trust’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-40,504
| Closed | -$1.37M | – | 4508 |
|
|
2025
Q4 | $1.37M | Buy |
40,504
+23,484
| +138% | +$729K | ﹤0.01% | 3204 |
|
|
2025
Q3 | $439K | Sell |
17,020
-7,719
| -31% | -$101K | ﹤0.01% | 3699 |
|
|
2025
Q2 | $198K | Sell |
24,739
-21,287
| -46% | -$162K | ﹤0.01% | 3939 |
|
|
2025
Q1 | $449K | Buy |
46,026
+15,326
| +50% | +$151K | ﹤0.01% | 3619 |
|
|
2024
Q4 | $388K | Buy |
30,700
+387
| +1% | +$4.92K | ﹤0.01% | 3749 |
|
|
2024
Q3 | $487K | Sell |
30,313
-4,082
| -12% | -$82.6K | ﹤0.01% | 3585 |
|
|
2024
Q2 | $839K | Sell |
34,395
-2,662
| -7% | -$123K | ﹤0.01% | 3318 |
|
|
2024
Q1 | $2.66M | Sell |
37,057
-1,066
| -3% | -$148K | ﹤0.01% | 2818 |
|
|
2023
Q4 | $7.58M | Buy |
38,123
+911
| +2% | +$113K | ﹤0.01% | 2250 |
|
|
2023
Q3 | $4.95M | Buy |
37,212
+1,268
| +4% | +$207K | ﹤0.01% | 2454 |
|
|
2023
Q2 | $5.38M | Buy |
35,944
+122
| +0.3% | +$19K | ﹤0.01% | 2464 |
|
|
2023
Q1 | $5.26M | Buy |
35,822
+4,423
| +14% | +$895K | ﹤0.01% | 2442 |
|
|
2022
Q4 | $4.97M | Buy |
31,399
+337
| +1% | +$53.9K | ﹤0.01% | 2492 |
|
|
2022
Q3 | $5.98M | Buy |
31,062
+378
| +1% | +$71.5K | ﹤0.01% | 2354 |
|
|
2022
Q2 | $4.48M | Buy |
30,684
+4,180
| +16% | +$557K | ﹤0.01% | 2589 |
|
|
2022
Q1 | $4.66M | Sell |
26,504
-333
| -1% | -$62.9K | ﹤0.01% | 2618 |
|
|
2021
Q4 | $7.88M | Sell |
26,837
-313
| -1% | -$83.7K | ﹤0.01% | 2406 |
|
|
2021
Q3 | $6.75M | Buy |
27,150
+3,938
| +17% | +$1.04M | ﹤0.01% | 2546 |
|
|
2021
Q2 | $5.9M | Buy |
23,212
+6,159
| +36% | +$1.15M | ﹤0.01% | 2741 |
|
|
2021
Q1 | $3.03M | Sell |
17,053
-1,796
| -10% | -$296K | ﹤0.01% | 3033 |
|
|
2020
Q4 | $2.98M | Buy |
18,849
+293
| +2% | +$63.7K | ﹤0.01% | 2978 |
|
|
2020
Q3 | $4.78M | Sell |
18,556
-78
| -0.4% | -$17.3K | ﹤0.01% | 2559 |
|
|
2020
Q2 | $4.33M | Buy |
18,634
+14,495
| +350% | +$2.24M | ﹤0.01% | 2606 |
|
|
2020
Q1 | $705K | Buy |
4,139
+2,282
| +123% | +$520K | ﹤0.01% | 3351 |
|
|
2019
Q4 | $410K | Buy |
+1,857
| New | +$342K | ﹤0.01% | 3600 |
|
Northern Trust's RAPT Position: Q1 2026 in Review
Northern Trust sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 40,504 shares — an estimated $1.37M sold.
Northern Trust first reported a position in RAPT in Q4 2019 and held it in 25 quarters. The position peaked at $7.88M in Q4 2021. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.
- Northern Trust reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
- Northern Trust sold 40,504 RAPT Therapeutics shares in Q1 2026, an estimated $1.37M.
- Northern Trust first reported a position in RAPT Therapeutics in Q4 2019 and held it in 25 quarters.
- Northern Trust's RAPT Therapeutics position peaked at $7.88M in Q4 2021.
- 0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.